Skip Navigation LinksHome > July 2005 - Volume 12 - Issue 4 > Mechanism of Action of Long-Acting Bronchodilators
Clinical Pulmonary Medicine:
doi: 10.1097/01.cpm.0000170112.09340.1a
Supplement Article

Mechanism of Action of Long-Acting Bronchodilators

DeBellis, Ronald J. PharmD, FCCP

Collapse Box


It has been suggested that the pathophysiology of chronic obstructive pulmonary disease is characterized by a centrally mediated increase in cholinergic tone. β-Agonists act by binding to adrenergic receptors, which stimulate bronchodilation through the mediation of the cyclic AMP (cAMP) second messenger system. Theophylline is postulated to stimulate bronchodilation by inhibiting phosphodiesterase and adenosine. Phosphodiesterase inhibition prolongs the actions of cAMP and results in bronchodilation. Inhaled long-acting anticholinergics work by antagonizing the actions of acetylcholine, producing relaxation of airway smooth muscle.

© 2005 by Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.